Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,084
Closed -$1.11M 802
2022
Q1
$1.11M Sell
20,084
-4,950
-20% -$262K 0.31% 76
2021
Q4
$1.3M Sell
25,034
-824
-3% -$42.1K 0.31% 65
2021
Q3
$1.29M Hold
25,858
0.31% 69
2021
Q2
$1.3M Buy
25,858
+4,000
+18% +$194K 0.3% 74
2021
Q1
$984K Sell
21,858
-1,661
-7% -$73.3K 0.28% 83
2020
Q4
$1M Buy
23,519
+5,559
+31% +$238K 0.3% 87
2020
Q3
$741K Sell
17,960
-14,000
-44% -$592K 0.21% 104
2020
Q2
$1.32M Buy
31,960
+19,000
+147% +$782K 0.35% 78
2020
Q1
$525K Sell
12,960
-81,000
-86% -$3.63M 0.15% 121
2019
Q4
$4.42M Sell
93,960
-7,000
-7% -$335K 0.82% 27
2019
Q3
$4.88M Sell
100,960
-32,000
-24% -$1.5M 0.88% 18
2019
Q2
$6.05M Sell
132,960
-36,800
-22% -$1.66M 1.06% 18
2019
Q1
$7.54M Buy
169,760
+49,000
+41% +$2.11M 1.49% 13
2018
Q4
$4.78M Buy
120,760
+112,806
+1,418% +$4.62M 0.86% 21
2018
Q3
$323K Sell
7,954
-13,931
-64% -$574K 0.06% 194
2018
Q2
$884K Sell
21,885
-88,500
-80% -$3.71M 0.15% 134
2018
Q1
$4.69M Buy
+110,385
New +$4.96M 0.94% 19
2016
Q1
Sell
-31,951
Closed -$1.33M 588
2015
Q4
$1.23M Buy
+31,951
New +$1.35M 0.17% 75

Other funds holding BCE

Exane Derivatives's BCE Position: Q2 2022 in Review

Exane Derivatives sold out of BCE (BCE) in Q2 2022, closing a stake of 20,084 shares — an estimated $1.11M sold.

Exane Derivatives first reported a position in BCE in Q4 2015 and held it in 18 quarters. The position peaked at $7.54M in Q1 2019. 601 funds tracked by Wall St. Rank hold BCE as of Q2 2022.

  • Exane Derivatives reported no remaining BCE position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 20,084 BCE shares in Q2 2022, an estimated $1.11M.
  • Exane Derivatives first reported a position in BCE in Q4 2015 and held it in 18 quarters.
  • Exane Derivatives's BCE position peaked at $7.54M in Q1 2019.
  • 601 funds tracked by Wall St. Rank held BCE as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.